IPX
IperionX Limited
$25.85
-2.51
(-8.85%)
Mkt Cap
867.53M
Volume
270,120
52W Range
21.66-61.45
Sector
Basic Materials
Beta
1.34
EPS (TTM)
-1.20
P/E Ratio
-26.25
Revenue (TTM)
0
Rev Growth (5Y)
N/A
EPS Growth (5Y)
N/A
Company Description
IperionX Limited primarily focuses on discovering and developing mineral resource sites. The company's geological surveys seek out valuable deposits, specifically targeting epithermal and replacement-style precious and base metals, alongside titanium, rare earth elements, silica sand, and zircon. It possesses complete ownership of the Milford project, which consists of 101 claims within Utah, United States. Additionally, IperionX fully controls the Titan project, an approximately 6,000-acre area located in Tennessee, United States. Established in 2017, the enterprise was initially known as Hyperion Metals Limited, subsequently changing its name to IperionX Limited in February 2022. Its corporate headquarters are based in Charlotte, North Carolina.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (35.35M) | (22.23M) | (17.44M) | (21.52M) | (13.28M) | (355,230) | (376,787) | (709,635) | (73,552) |
| EPS | -1.20 | -1.00 | -1.50 | -1.60 | -0.75 | -0.03 | -0.03 | -0.05 | -0.00 |
| Free Cash Flow | (39.41M) | (26.68M) | (18.57M) | (14.06M) | (3.62M) | (3,369) | (923) | (242) | 0 |
| FCF / Share | -1.34 | -1.22 | -1.11 | -1.04 | -0.27 | -0.00 | -0.00 | -0.00 | N/A |
| Operating CF | (21.80M) | (18.68M) | (15.86M) | (12.13M) | (3.56M) | (311) | (502) | (226) | 0 |
| Total Assets | 105.03M | 55.44M | 22.80M | 9.91M | 2.79M | 2.05M | 2.51M | 3.20M | 13,806 |
| Total Debt | 3.93M | 1.49M | 975,314 | 543,030 | 475,652 | 17,873 | 0 | 0 | 50,837 |
| Cash & Equiv | 54.81M | 33.16M | 11.94M | 5.67M | 1.70M | 1.14M | 1.73M | 2.69M | 0 |
| Book Value | 92.44M | 51.34M | 20.56M | 7.42M | 1.76M | 1.98M | 2.47M | 3.01M | (71,402) |
| Return on Equity | -0.38 | -0.43 | -0.85 | -2.90 | -7.54 | -0.18 | -0.15 | -0.24 | N/A |
| Metric | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| Net Income | (34.83M) | (35.33M) | (16,236) | (5,674) | (5,247) | (4,345) | (4,377) | (5,479) | (5,281) | (13.27M) | (6,525) | (98) |
| EPS | -10.40 | -0.00 | -0.06 | -0.05 | -5.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.75 | -0.00 | 0.00 |
| Free Cash Flow | (14.22M) | (39.39M) | (16,232) | (1.08M) | (4.76M) | (385,136) | (530,795) | (4.28M) | (3.20M) | (3.62M) | (526) | (111) |
| FCF / Share | -4.23 | -1.34 | -0.00 | -0.05 | -0.23 | -0.02 | -0.04 | -0.31 | -0.24 | -0.27 | -0.00 | -0.00 |
| Operating CF | (8.88M) | (10.10M) | (11.70M) | (5,316) | (3.76M) | (4,136) | (3,795) | (3.12M) | (2.95M) | (3.56M) | (451) | (87) |
| Total Assets | 129.16M | 105.03M | 115.83M | 55.44M | 34.04M | 22.80M | 18.00M | 9.91M | 16.16M | 2.79M | 9.51M | 2.05M |
| Total Debt | 4.46M | 3.93M | 4.19M | 1.49M | 1.68M | 975,314 | 1.15M | 543,030 | 558,887 | 475,652 | 0 | 17,873 |
| Cash & Equiv | 65.83M | 54.81M | 77.13M | 33.16M | 17.33M | 11.94M | 11.44M | 5.67M | 14.26M | 1.70M | 1.94M | 1.14M |
| Book Value | 108.20M | 92.44M | 105.54M | 51.34M | 30.18M | 20.56M | 15.38M | 7.42M | 15.05M | 1.76M | 9.30M | 1.98M |
| Return on Equity | -0.32 | -0.38 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -7.54 | -0.00 | -0.00 |
IPX News
IperionX Announces Pricing of Public Offering of American Depositary Shares
IperionX Completes Strategic Camden Acquisition - Unlocking Ultra-High-Grade Critical Minerals to Accelerate U.S. Supply Chain
IperionX Awarded Up to US$6.6M by OSW-SWIB to Scale U.S. Titanium Plate for Defense Applications
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations
IperionX to Acquire Rights to Rare Earth and Critical Mineral Assets Adjacent to Titan Project
IperionX: Titan Definitive Feasibility Study (DFS) Presentation
IperionX Titan DFS Confirms High-Return U.S. Rare Earths and Critical Minerals Project
U.S. Army Testing Shows Iperionx Titanium Fasteners Exceed Grade 8 Steel Torque-To-Yield Performance
IperionX Commissions Six-Axis Powder Metallurgy Press, Expanding U.S. Titanium Component Manufacturing Capabilities
IPX1031 Expands Midwest Presence with Scott Schofield